|
SOS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.84429999997116E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.48510000039937E-07 |
| Normal-vs-Stage2 |
3.482100E-03 |
| Normal-vs-Stage3 |
2.924400E-02 |
| Normal-vs-Stage4 |
4.777900E-02 |
| Stage1-vs-Stage2 |
8.608200E-01 |
| Stage1-vs-Stage3 |
2.829400E-01 |
| Stage1-vs-Stage4 |
7.773400E-01 |
| Stage2-vs-Stage3 |
3.003000E-01 |
| Stage2-vs-Stage4 |
8.876600E-01 |
| Stage3-vs-Stage4 |
3.425000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.71429999996332E-07 |
| Normal-vs-AfricanAmerican |
2.310000E-02 |
| Normal-vs-Asian |
1.101670E-02 |
| Caucasian-vs-AfricanAmerican |
3.558200E-01 |
| Caucasian-vs-Asian |
8.320800E-01 |
| AfricanAmerican-vs-Asian |
6.398800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.84560000004996E-06 |
| Normal-vs-Female |
3.955900E-03 |
| Male-vs-Female |
4.457000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.381840E-02 |
| Normal-vs-Extreme_Weight |
2.1304999997529E-07 |
| Normal-vs-Obese |
2.537400E-03 |
| Normal-vs-Extreme_Obese |
4.158800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.684400E-01 |
| Normal_Weight-vs-Obese |
7.446600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.879400E-01 |
| Extreme_Weight-vs-Obese |
8.166000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.307000E-01 |
| Obese-vs-Extreme_Obese |
9.219600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.756200E-03 |
| Normal-vs-Age(41-60Yrs) |
6.166700E-04 |
| Normal-vs-Age(61-80Yrs) |
7.20449999991324E-07 |
| Normal-vs-Age(81-100Yrs) |
4.023200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.785200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.053600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.047000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.668170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.814800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.442200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.62409999995938E-06 |
| Normal-VS-Type2 PRCC |
1.916570E-03 |
| Normal-VS-KIRP CIMP |
3.549700E-02 |
| Normal-VS-Unclassified PRCC |
4.460500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.149800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.341000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.509400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.042600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.465400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.731000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.66529999965104E-07 |
| Normal-vs-N1 |
1.698360E-01 |
| Normal-vs-N2 |
1.14690000052597E-07 |
| N0-vs-N1 |
3.729800E-02 |
| N0-vs-N2 |
2.984500E-02 |
| N1-vs-N2 |
1.135670E-02 |
|
|
